001     169048
005     20231120155329.0
024 7 _ |a 10.1002/alz.12830
|2 doi
024 7 _ |a pmid:36453876
|2 pmid
024 7 _ |a 1552-5260
|2 ISSN
024 7 _ |a 1552-5279
|2 ISSN
024 7 _ |a altmetric:139582350
|2 altmetric
037 _ _ |a DZNE-2022-01770
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Grazia, Alice
|0 P:(DE-2719)9001307
|b 0
|e First author
245 _ _ |a Feasibility of a standard cognitive assessment in European academic memory clinics.
260 _ _ |a Hoboken, NJ
|c 2023
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1687164086_9363
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Standardized cognitive assessment would enhance diagnostic reliability across memory clinics. An expert consensus adapted the Uniform Dataset (UDS)-3 for European centers, the clinician's UDS (cUDS). This study assessed its implementation acceptability and feasibility.We developed a survey investigating barriers, facilitators, and willingness to implement the cUDS. With a mixed-methods design, we analyzed data from academic memory clinics.Seventy-eight percent of responding clinicians were experienced neuropsychologists/psychologists and 22% were medical specialists coming from 18 European countries. Sixty-five percent clinicians were willing to implement cUDS. General barriers related to implementation (43%) and clinical-methodological domains (21%). Favorable clinicians reported finances (15%) and digitalization (9%) as facilitating, but unavailability of local norms (23%) as hindering. Unfavorable clinicians reported logistical (23%) and time issues (18%).Despite challenges, data showed moderate clinicians' acceptability and requirements to improve feasibility. Nonetheless, these results come from academic clinicians. The next steps will require feasibility evaluation in non-academic contexts.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Alzheimer's disease
|2 Other
650 _ 7 |a implementation feasibility
|2 Other
650 _ 7 |a mild cognitive impairment
|2 Other
650 _ 7 |a mixed-methods
|2 Other
650 _ 7 |a standard cognitive assessment
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Feasibility Studies
|2 MeSH
650 _ 2 |a Reproducibility of Results
|2 MeSH
650 _ 2 |a Surveys and Questionnaires
|2 MeSH
650 _ 2 |a Cognition
|2 MeSH
650 _ 2 |a Europe
|2 MeSH
700 1 _ |a Altomare, Daniele
|b 1
700 1 _ |a Preis, Lukas
|0 P:(DE-2719)9000703
|b 2
|u dzne
700 1 _ |a Monsch, Andreas U
|b 3
700 1 _ |a Cappa, Stefano F
|b 4
700 1 _ |a Gauthier, Serge
|b 5
700 1 _ |a Frölich, Lutz
|0 P:(DE-2719)9001189
|b 6
|u dzne
700 1 _ |a Winblad, Bengt
|b 7
700 1 _ |a Welsh-Bohmer, Kathleen A
|b 8
700 1 _ |a Teipel, Stefan J
|0 P:(DE-2719)2000026
|b 9
700 1 _ |a Boccardi, Marina
|0 P:(DE-2719)9000492
|b 10
|e Last author
773 _ _ |a 10.1002/alz.12830
|g p. alz.12830
|0 PERI:(DE-600)2201940-6
|n 6
|p 2276-2286
|t Alzheimer's and dementia
|v 19
|y 2023
|x 1552-5260
856 4 _ |u https://pub.dzne.de/record/169048/files/DZNE-2022-01770%20SUP1.zip
856 4 _ |u https://pub.dzne.de/record/169048/files/DZNE-2022-01770%20SUP2.doc
856 4 _ |u https://pub.dzne.de/record/169048/files/DZNE-2022-01770%20SUP2.docx
856 4 _ |u https://pub.dzne.de/record/169048/files/DZNE-2022-01770%20SUP2.odt
856 4 _ |u https://pub.dzne.de/record/169048/files/DZNE-2022-01770%20SUP2.pdf
856 4 _ |u https://pub.dzne.de/record/169048/files/DZNE-2022-01770.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/169048/files/DZNE-2022-01770.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:169048
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9001307
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 2
|6 P:(DE-2719)9000703
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 6
|6 P:(DE-2719)9001189
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)2000026
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)9000492
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-11
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2022-11-11
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-11
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-25
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2023-10-25
920 1 _ |0 I:(DE-2719)5000062
|k AG Boccardi
|l Implementation Neuroscience
|x 0
920 1 _ |0 I:(DE-2719)1510100
|k AG Teipel
|l Clinical Dementia Research Rostock /Greifswald
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)5000062
980 _ _ |a I:(DE-2719)1510100
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21